Condensed Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Operating expenses
Research and development	$ 12,449	$ 8,713
General and administrative	5,325	4,422
Total operating expenses	17,774	13,135
Loss from operations	(17,774)	(13,135)
Other income (expense)
Interest income	4,005	1,832
Interest expense	(1,000)	0
Change in fair value of embedded derivatives	(50)	0
Other expense, net	(54)	(4)
Total other income	2,901	1,828
Net loss	(14,873)	(11,307)
Other comprehensive gain (loss)
Unrealized loss on marketable securities	(456)	227
Comprehensive loss	$ (15,329)	$ (11,080)
Net loss per common share, basic (in dollars per share)	$ (0.25)	$ (0.28)
Net loss per common share, diluted (in dollars per share)	$ (0.25)	$ (0.28)
Weighted-average shares outstanding, basic (in shares)	59,812,000	41,025,062
Weighted-average shares outstanding diluted (in shares)	59,812,000	41,025,062